Delivery Order SPE2DB22D1103-SPE2DB25FH2K0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a prescription medication used to treat autoimmune conditions. This firm fixed-price delivery order, valued at $3,776.50, is scheduled for completion by September 15, 2025, and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $9,883.59 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered from...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in the treatment of autoimmune conditions. This competitively awarded, non-set-aside delivery order carries a firm fixed price ceiling value of $7,652.27 and is scheduled for completion by September 16, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used to treat autoimmune conditions. This competitively awarded, firm fixed-price delivery order has a ceiling value of $2,265.90 and is set to complete by August 13, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside award, this...
- The Defense Logistics Agency awarded a delivery order valued at $12,823.53 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on September 12, 2025, with an ultimate completion date of September 15, 2025. This is a firm fixed price, non-competitive delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. HUMIRA is a widely used...
- The Defense Logistics Agency awarded a delivery order valued at $1,132.95 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in treating inflammatory conditions. The contract was awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, and utilizes firm fixed pricing with no set-aside designation. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL with a ceiling value of $2,265.90 and a firm fixed price. The delivery order is scheduled for completion by August 4, 2025, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. This award utilized no set-aside designation and was competitively awarded through the company's existing contract vehicle. HUMIRA...
- The Defense Logistics Agency awarded a $9,063.60 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL units on August 26, 2025, with a completion date of August 27, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. HUMIRA is a widely-used pharmaceutical for treating autoimmune and inflammatory conditions, and this contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,482.94 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on August 12, 2025, with completion targeted for August 13, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. HUMIRA is a widely used biologic immunosuppressant medication commonly prescribed for rheumatoid arthritis,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,542.07 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. HUMIRA is a leading biologic immunosuppressant medication used to treat various...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FH2K0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL with a ceiling value of $1,142.05. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The contract is scheduled for completion by September 17, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. HUMIRA is a biologic immunosuppressant medication commonly used in the treatment of various autoimmune conditions including rheumatoid arthritis, Crohn's disease, and other inflammatory disorders within military and federal healthcare systems. This delivery order represents a task issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare programs globally. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill federal procurement requirements across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles designed to support military personnel and veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/16/25 |